Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease
Clinical trial NCT02980263 · WITHDRAWN
Trial details
- NCT number
- NCT02980263
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2017-11-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.